• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Muscular Atrophy

Muscular Atrophy - 50 Studies Found

Active, not recruiting : A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
: Spinal Muscular Atrophy
: 2013-04-22
: Drug: nusinersen Administered by intrathecal (IT) injection
Completed : An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
: Spinal Muscular Atrophy
: 2011-12-13
: Drug: nusinersen Administered by intrathecal (IT) injection
Completed : A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
: Spinal Muscular Atrophy
: 2014-11-12
:
  • Drug: nusinersen Administered

Completed : A Trial of Hydroxyurea in Spinal Muscular Atrophy
: Spinal Muscular Atrophy
: 2007-06-11
: Drug: Hydroxyurea
Recruiting : Prospective Evaluation of Infants With Spinal Muscular Atrophy:
: Spinal Muscular Atrophy
: 2016-07-01
Terminated : A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)
: Muscular Atrophy, Spinal
: 2014-09-11
:
  • Drug: RO6885247 oral solution

Completed : A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Infants With Type1 Spinal Muscular Atrophy (Firefish)
: Muscular Atrophy, Spinal
: 2016-09-21
: Drug: RO7034067 RO7034067 will be administered orally.
Completed : A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Type 2 and 3 Spinal Muscular Atrophy Participants (Sunfish)
: Muscular Atrophy, Spinal
: 2016-09-19
:
  • Drug: Placebo Placebo will be

Completed : A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
: Muscular Atrophy, Spinal
: 2007-12-04
: Drug: Hydroxyurea
Completed : A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
: Muscular Atrophy, Spinal
: 2007-12-04
: Drug: Hydroxyurea
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.